Premium
Hypothesis of zinc ascorbate as best zinc ionophore for raising antiviral resistance against Covid‐19
Author(s) -
Cingolani Valentino
Publication year - 2021
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.26989
Subject(s) - zinc , ionophore , virology , intracellular , covid-19 , chemistry , virus , biology , pharmacology , medicine , biochemistry , membrane , disease , organic chemistry , infectious disease (medical specialty)
Highlights Zinc ascorbate could prevent and treat Covid‐19 by raising antiviral resistance to SARS‐CoV‐2 virus via increase of intracellular zinc concentration as a zinc ionophore more than other salts of zinc or zinc with vitamin C. Tests in vitro and clinical trials for Covid‐19 prevention and treatment with zinc ascorbate are strongly recommended and should start as soon as possible. Potential advantages of zinc ascorbate supplementation over vaccines and drugs are also discussed, with supplementation suggestions.